secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001819790-26-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals furnishes corporate presentation; no material updates identified
--------------------------------------------------------------------------------

- Corporate presentation published January 12, 2026, on company website.
- Presentation highlights XDEMVY eye care product; no new financial or clinical data provided.
- Routine Regulation FD disclosure; no guidance changes or strategic announcements.
- Furnished excerpt does not contain specific numbers or events beyond product branding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000002/0001819790-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000002/tars-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001819790-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer